Related Experiment Video

Updated: Jul 19, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Recent insights into the mechanisms of antifungal resistance

Katherine S Barker1, P David Rogers

  • 1Room 304 West Patient Tower, LeBonheur Children's Medical Center, 50 North Dunlap Street, Memphis, TN 38103, USA.

Current Infectious Disease Reports
|October 27, 2006
PubMed

Insights

Antifungal resistance in fungal infections is rising, especially in immunocompromised patients. Understanding resistance mechanisms is crucial for developing new treatments against evolving fungal pathogens.

Area of Science:

  • Medical Mycology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Increasing incidence of fungal infections, particularly invasive types.
  • Limited antifungal agents and growing resistance pose treatment challenges.
  • Immunocompromised individuals are at higher risk.

Purpose of the Study:

  • To review current understanding of antifungal resistance mechanisms.
  • To highlight recent advances in azole, amphotericin B, and echinocandin resistance.
  • To discuss future research directions in antifungal resistance.

Main Methods:

  • Literature review of recent research on fungal resistance.
  • Analysis of molecular mechanisms of antifungal drug resistance.
  • Synthesis of findings on transcriptional regulation and specific resistance pathways.

Main Results:

  • Clarified transcriptional regulation of azole resistance in Candida species.
  • Elucidated mechanisms of intrinsic resistance to amphotericin B.
  • Detailed acquired resistance mechanisms to echinocandins.

Conclusions:

  • Significant progress in understanding antifungal resistance.
  • Undiscovered resistance determinants remain.
  • Emergence of resistance to new antifungal agents is expected.

More Related Videos

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure10:33

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure

Published on: May 27, 2022

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...